PRKAA1 and type 2 diabetes mellitus: Decreases hepatic glucose production, lowers blood glucose and insulin levels, improves glucose tolerance, inhibits gluconeogenesis, and activates AMPK signaling, potentially beneficial for managing type 2 diabetes.